Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ETR vs GSK✓SelectedUSD · GSKETR vs GSK performance historyLatest closeAs of-1.69%11/19
Stock and ETF performance explorer

ETR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+349.0%
GSK return
+97.7%
Excess return
+251.4%
Maximum drawdown
-42.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.7%-1.6%-0.1%-1.1%
7D-4.6%-4.7%+0.1%-2.9%
30D+1.6%-4.7%+6.3%+3.3%
3M-1.0%-8.8%+7.7%+2.0%
6M-2.8%-4.6%+1.8%-1.7%
YTD+17.7%+1.0%+16.7%+15.6%
1Y+15.7%+6.9%+8.8%+11.1%
3Y+134.9%+52.5%+82.3%+87.3%
5Y+137.8%+40.3%+97.6%+92.6%
All+349.0%+97.7%+251.4%+200.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling